22May
28Apr
Never A Dull Moment Podcast “Best Of”
Never A Dull Moment Podcast with Ziad and his guests releases a "Best Of" the first 10 episodes. New episodes with more guests, talk shows and startups to come soon!
13Feb
Matchmaking service Tawkify picks up ‘anti-superficial’ dating app S’More in mobile expansion
Matchmaking service provider Tawkify announced today it acquired S’More, an “anti-superficial” dating app that had experimented with blurred profile photos, and even blurred video chats, in an attempt to get people to get to know one another without the focus on physical appearance. With the acquisition, S’More is sunsetting its app, and founder Adam Cohen-Aslatei will instead join the Tawkify team to lead the launch of its first-ever mobile product. Deal terms were not disclosed, but S’More had raised $3.2 million in seed funding, according to Crunchbase. Set...
04Nov
Pyramid Biosciences to Present at the 2022 Jefferies London Healthcare Conference
Pyramid Biosciences, Inc., a privately-held, clinical-stage biotechnology company focused on developing new and highly differentiated precision therapies for cancer and other serious diseases, announced today that Chief Executive Officer, Brian Lestini, M.D., Ph.D., will present at the 2022 Jefferies London Healthcare Conference on Thursday, November 17, 2022 at 2:40 PM GMT. Read more >>
02Nov
Akston Biosciences Announces Positive Interim Phase II Results from COVID “Universal” Booster Vaccine Trial
Akston Biosciences Corporation, a developer of new classes of biologic therapeutics, today announced top-line clinical results for its Phase II COVID-19 “universal” booster vaccine, AKS-452. An interim analysis of the data found that 93% of subjects previously vaccinated with Pfizer, Moderna, Johnson & Johnson (Janssen), and AstraZeneca vaccines showed an increase in neutralizing antibody titers after receiving a single dose of AKS-452. The average neutralization titers across all subjects increased 4-fold against the Wuhan strain and 5-fold against the Omicron...
28Oct
Legally blind man can see 20/20 vision again and inspires others with his story
More than 280,000 Ohioans are considered legally blind. Luckily for some, there are medical devices available to help correct their vision. Aside from it being extremely expensive getting a pair of these glasses, which is through the company, 'eSight', Benjamin Murray explained being legally blind comes with a long list of challenges in itself. "You know, it's hard to think about everyday life when you can't see," 33-year-old Murray said. He was considered legally blind for 26 years. In 2015,...
26Oct
U.S. Senator Richard Blumenthal (D-CT) Tours Landsdowne Labs
“Children swallow button batteries. That’s the reality of our world. Because the batteries become loose from devices, and then can literally burn through the throat of a young child. It happens again and again…[leading to] years of treatment, surgery, and therapy.” So said U.S. Senator Richard Blumenthal, D-CT, on an October 7 visit to Landsdowne Labs, at Fairfield University, in Fairfield, CT. Link to video of remarks. Landsdowne has since received a patent for technology that rapidly reduces chemical reactions...
24Oct
At the Forefront of Change says Ziad Moukheiber
"It is our responsibility as the Angel Investing community to be at the forefront of change #investingforabetterwork. We have no choice but to change our habbits to set a good example. Travel less and to see friends and family not for a one hour meeting! Cut plastics out of our lives! Fix things don’t buy new! And more… It is shocking to see the irreversible damage made to the environmen t! The list is long of what we can do and what we...
20Oct
Meet The New Unicorns Minted In September 2022
Twelve companies joined The Crunchbase Unicorn Board in September 2022, adding $19.6 billion in value to the board. These companies have raised $3.8 billion total in funding with 62% of that amount raised in September 2022. Wasabi on list. Read more >>
20Oct